Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Treasury Shares (2019 - 2025)

Cellebrite DI's Treasury Shares history spans 6 years, with the latest figure at $85000.0 for Q4 2025.

  • Quarterly Treasury Shares changed 0.0% to $85000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $85000.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $85000.0 for FY2025, 0.0% changed from the prior year.
  • Treasury Shares came in at $8.0 million for Q4 2025, up from $7.3 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $8.2 million in Q4 2023 to a low of $2.0 million in Q4 2021.
  • The 5-year median for Treasury Shares is $7.3 million (2024), against an average of $6.4 million.
  • The largest YoY upside for Treasury Shares was 0.0% in 2021 against a maximum downside of 0.0% in 2021.
  • Cellebrite DI's Treasury Shares stood at $85000.0 in 2021, then changed by 0.0% to $85000.0 in 2022, then changed by 0.0% to $85000.0 in 2023, then changed by 0.0% to $85000.0 in 2024, then changed by 0.0% to $85000.0 in 2025.
  • Per Business Quant, the three most recent readings for CLBT's Treasury Shares are $85000.0 (Q4 2025), $85000.0 (Q4 2024), and $85000.0 (Q4 2023).